News
AbbVie is paying ADARx Pharmaceuticals $335 million upfront to secure options on next-gen small interfering RNA (siRNA) ...
9h
Fintel on MSNCitigroup Downgrades AbbVie (ABBV)Fintel reports that on May 14, 2025, Citigroup downgraded their outlook for AbbVie (NYSE:ABBV) from Buy to Neutral. Analyst ...
Samples couriered between Auckland and Wellington have been mislaid twice, according to union representing lab workers.
14h
Fintel on MSNLeerink Partners Downgrades iTeos Therapeutics (ITOS)Fintel reports that on May 14, 2025, Leerink Partners downgraded their outlook for iTeos Therapeutics (NasdaqGM:ITOS) from ...
Among the most serious problems contributing to K-12 science education’s decline, they noted, were a general degradation of ...
Collaboration combines Novo Nordisk's scientific leadership in obesity and cardiometabolic diseases with Septerna's expertise in G protein-coupled receptor (GPCR) drug discovery Goal is to develop mul ...
Hyderabad: CuraTeQ Biologics s.r.o., a wholly owned step-down subsidiary of Aurobindo Pharma Ltd, has obtained marketing ...
7h
Live Science on MSNImmune genes linked to bigger brains and longer lifespans in mammals — including humansThe genomes of long-living, big-brained mammal species reveal that they carry more copies of immunity genes. Experts ...
Brown isn’t shooting the ball particularly well versus New York, firing at a 22.6% clip from 3-point land. He’s making less than two 3-pointers on almost eight chucks from distance per game ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results